UNITED STATES CUTANEOUS LYMPHOMA C… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2009

Legal Domicile

Principal Officer

ALEJANDRO GRU MD

Phone

8662705332

Tax Period

2024-01-01 to 2024-12-31

UNITED STATES CUTANEOUS LYMPHOMA CONSORTIUM, founded in 2009, is a small nonprofit in the Diseases & Disorders sector that reported $163K in total revenue in fiscal year 2024. Revenue fell 30% from the prior year — a significant decline worth monitoring. Expenses of $230K exceeded revenue, resulting in a 41% operating deficit.

Mission

THE MISSION OF THE USCLC IS TO FOSTER A MULTIDISCIPLINARY APPROACH TO PATIENT CARE, EDUCATION, AND CLINICAL AND BASIC RESEARCH IN THE AREA OF CUTANEOUS LYMPHOMAS.

Program Service Accomplishments

Program 1

Expenses: $79,433 Revenue: $149,725

ANNUAL WORKSHOP - THE USCLC BRINGS COLLEAGUES TOGETHER ANNUALLY FOR A ONE- DAY WORKSHOP WHICH INCLUDES EXHIBITORS.

Program 2

Expenses: $81,646

REGISTRY - CONDUCTING A STUDY OF A U.S. BASED REGISTRY FOR CUTANEOUS LYMPHOMA. THE REGISTRY WOULD COME UNDER THE JURISDICTION OF THE USCLC AND WOULD ENABLE DOCTORS AND INVESTIGATORS TO PARTICIPATE IN PROVIDING DATA AND TO HAVE ACCESS TO CASES, TREATMENT, AND OTHER STATISTICAL DATA RELATED TO CUTANEOUS LYMPHOMA.

Program 3

YOUNG PHYSICIAN MENTORSHIP - DESIGNED TO ALLOW INTERESTED PHYSICIANS TO EXPLORE THE FIELD OF CUTANEOUS LYMPHOMA WITH AN EXPERIENCED MENTOR WHILE ALSO GAINING PRACTICAL KNOWLEDGE ABOUT THE WORKFLOW OF...

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $9,635

Program Service Revenue $149,725

Investment Income $3,962

Other Revenue $0

TOTAL REVENUE $163,322

Expense Breakdown

Grants Paid $2,500

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $163,579

Other Expenses $227,664

TOTAL EXPENSES $230,164

Year-over-Year Comparison

	2024	2023	Change
Revenue	$163,322	$232,631	-0.3%
Expenses	$230,164	$230,206	0.0%
Net Income	$-66,842	$2,425	-28.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ALEJANDRO GRU MD	PRESIDENT	0.30	Officer Director	$0	$0	$0
LARISA GESKIN MD	SECRETARY/TR	0.30	Officer Director	$0	$0	$0
FRANCINE FOSS MD	IMMEDIATE PA	0.30	Officer Director	$0	$0	$0
STEPHAN BARTA MD	DIRECTOR	0.30	Director	$0	$0	$0
ANNE BEAVEN MD	DIRECTOR	0.30	Director	$0	$0	$0
KIM BOHJANEN MD	DIRECTOR	0.30	Director	$0	$0	$0
AURIS HUEN MD	DIRECTOR	0.30	Director	$0	$0	$0
MARY JO LECHOWICZ MD	DIRECTOR	0.30	Director	$0	$0	$0
AARON MANGOLD MD	DIRECTOR	0.30	Director	$0	$0	$0
AMY MUSIEK MD	DIRECTOR	0.30	Director	$0	$0	$0
MICHI SHINOHARA MD	DIRECTOR	0.30	Director	$0	$0	$0
PEGGY WU MD	DIRECTOR	0.30	Director	$0	$0	$0
ELISE OLSEN MD	REGISTRY CO-	0.30	Director	$0	$0	$0
JOI CARTER MD	REGISTRY CO-	0.30	Director	$0	$0	$0
SHARON KIM	EXECUTIVE DI	4.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$163,322	$230,164	$641,906	$-66,842
2023	$232,631	$230,206	$711,996	$2,425
2022	$309,126	$141,055	$710,859	$168,071
2021	$99,933	$124,040	$540,921	$-24,107
2020	$201,300	$141,559	$564,791	$59,741
2019	$181,550	$204,460	$464,777	$-22,910
2018	$196,716	$245,158	$487,687	$-48,442

UNITED STATES CUTANEOUS LYMPHOMA CONSORTIUM